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Discussion and future work:

Results:

Introduction:

Soybeans contain a low molecular
weight (5kDa) bioactive peptide called
lunasin, which possess
chemotherapeutic, anti-inflammatory,
and anticarcinogenic properties (1).
Current strategies for obtaining
lunasin are too complicated and
expensive to be widely utilized.
Soybeans can be processed to make
tofu, yielding whey and okara as
major by-products (2). However, the
potential for these by-products as a
possible source of lunasin remains
unexplored. Therefore, the aim of this
study was to establish if tofu byproducts can be easily utilized as
sources of lunasin enriched material.
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Conclusion:

Our results indicate that tofu whey
can be used as an alternative source
of lunasin enriched material via
calcium precipitation.

Methods:

Tofu was prepared from soybeans by
a standardized procedure, and
calcium was used to induce
preferential precipitation of lunasin
present in the whey. Precipitate and
supernatant fractions obtained were
characterized by measuring protein
profile (Electrophoresis), total soluble
protein content (Bradford assay),
lunasin content (Western blot ) (3),
and presence of isoflavones (HPLC).

Addition of calcium to the whey
promoted precipitation of small
proteins, producing a liquid fraction
with a wide distribution of proteins,
and a solid fraction containing low
molecular weight proteins (<15kDa).
The lower content of soluble proteins
and higher content of lunasin of WL
and WS, compared to DSF, suggest
the successful concentration of the
bioactive peptide, while maintaining
a negligible amount of isoflavones.
Treatment and characterization of
okara as a possible source of lunasin
enriched material will be our next
step.
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Figure 1. Process for
tofu preparation and
obtention of lunasin
enriched whey fractions

Figure 2. Characterization of tofu whey solid and liquid fractions.
Defatted soy flour (DSF) and commercial pure lunasin standard (STD ) were used
to compare protein profile and quantify lunasin content in whey solid (WS) and
liquid (WL) fractions. (A) Protein distribution profile by gel electrophoresis. (B)
Western blot for lunasin standard curve and samples. (C) Plot of lunasin standard
curve presented in Fig.2B, and used for quantification of lunasin. (D) Results for
soluble proteins, lunasin and isoflavones content in samples.
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